Reaction
Vith Nerve Paralysis reporting signals
As of the last recalculation, Vith Nerve Paralysis appears in 1,126 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is MELPHALAN (PRR 19.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Melphalan | 23 | 19.1 | 19.1 |
| Tretinoin | 8 | 18.3 | 18.4 |
| Melphalan Hydrochloride | 23 | 17.3 | 17.3 |
| Obinutuzumab | 12 | 13.6 | 13.6 |
| Micafungin Sodium | 6 | 13.1 | 13.2 |
| Bupivacaine | 6 | 11.9 | 11.9 |
| Thiotepa | 6 | 11.7 | 11.7 |
| Ipilimumab | 18 | 7.8 | 7.8 |
| Temozolomide | 8 | 7.1 | 7.1 |
| Faricimab | 3 | 6.9 | 6.9 |
| Nivolumab | 33 | 6.5 | 6.5 |